ITL Group announced as KEiBA 2017 finalist

Kent-based ITL Group was among the 50 finalists unveiled at the Kent Vision Live exhibition at the Kent Event Centre in Detling last week. ITL has been nominated as a finalist for Technology Business of the Year at the Kent Enterprise in Business Awards (KEiBA) 2017.

Now in its 9th year, the Kent Excellence in Business Awards is an annual awards ceremony staged and produced by KM Media Group and Kent County Council to recognise and reward excellence in Kent’s businesses.

Tom Cole, ITL Group CEO commented:

“We are thrilled to once again be nominated as a finalist for KEiBA. For the past 40 years, our mission has been to deliver the products and services that can indeed change lives”

2017 is a celebration for ITL Group, as we continue to celebrate 40 years in the Med Tech industry. Founded in 1977, Ashford-based ITL have become a successful design and manufacturing partner for leading life-saving medical technology.

To read the full list of KEiBA finalists click here

You may also like...

News
ITL increases critical instrument production during COVID-19 pandemic

As a global design and manufacturing partner of life-saving medical devices and diagnostic instruments, ITL Group (a G&H company) is an essential link in the healthcare supply chain. ITL is currently manufacturing and delivering instrumentation designed to improve respiratory function and oxygen uptake as part of a ventilator system for patients in critical care including those due to COVID-19, as well as hygiene monitoring devices and rapid diagnostic testing platforms.

Read more >

Resource
COVID-19 & MedTech: How to effectively manage supply chain disruption

It’s impossible to anticipate the arrival of global crises such as COVID-19, but the resulting impact on supply chains is putting added pressure on manufacturers worldwide – but what action can you take to build a more resilient supply chain in a time of crisis?

Read more >

Case Study
Magnasense

From lab based analysis to mobile and disposable ‘point of care testing’ (POCT)

View this case study >